Alzheimer's Disease Clinical Trials in Houston

Showing 41-60 of 220 trials

Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology

NCT05184569

The purpose of the study is to test the safety and tolerability of twice daily Verdiperstat in patients with semantic variant primary progressive aphasia (svPPA) due to frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP). Three-fourths of the participants will receive Verdiperstat and one-fourth will receive Placebo during the 24-week treatment duration.

Semantic Dementia

Peter Ljubenkov, MD64 participantsStarted Apr 2022

San Francisco, California, United States • Chicago, Illinois, United States • Rochester, Minnesota, United States +2 more locations

TERMINATEDPhase 3< 1 mile

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

NCT02446132

This was an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305.

Agitation in Patients With Dementia of the Alzheimer's Type

Otsuka Pharmaceutical Development & Commercialization, Inc.1,197 participantsStarted Nov 2015

Chandler, Arizona, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +224 more locations

Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Alzheimer's Disease Trials in Other Cities

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

Self-Administered Interactive Exercise Program (Tele-Exergame)

A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease

Alzheimer's Plasma Extension

Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease

Patient Priorities Care for Hispanics With Dementia

A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

The Care Ecosystem Consortium Effectiveness Study

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.

A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation

Other Conditions in Houston